Elaia

As the European tech ecosystem enjoys the summer, what’s better than a bit of reading near your preferred scenic route? Each week this August, we’ll share a selection of reads from our Medium to accompany you on your travels this summer. 🧐 What does Waldo have to do with synthetic data? Arturo Ancira García dives into the rise of synthetic data in an AI-world and what it means for the future of computing. With insights from GLEAMER and Hugging Face, learn more about how we’ve (nearly) eaten the internet, the key kinds of synthetic data, and why we’re keeping an eye on this emerging field here at Elaia. Full article available here 👉 https://lnkd.in/eqS_vS4u

🎨 Ever wondered what artists and entrepreneurs have in common? Featured in Maddyness's Summer Tribune Series, Elaia's Communications & Community Manager, Anya Brochier, shines a light on the shared traits between these two profiles. From passion-driven work to supportive ecosystems, artists and entrepreneurs might not be so different after all. Read more in Maddyness (thank you Etienne Portais and Maxence Fabrion!) ➡️ https://lnkd.in/e6gWUsvQ

☀️ As the European tech ecosystem enjoys the summer, what’s better than a bit of reading? Each week this August, we’ll share a selection of reads from our Medium to accompany you on your travels this summer. 🧠 GenAI, GenAI, it’s the topic on everyone’s mind… That’s why we recently chatted with experts from Bain, Google, and L’Oréal at the Elaia offices to hear more about how they’re seeing companies embrace GenAI. With each speaker offering a look at a different layer of the GenAI stack, we invite you to discover more about how they see the impact of GenAI on the foundation, service and application levels. 🕵️♀️ Here’s a few hints at our takeaways: With the tech play evolving, it’s time to look at applications. GenAI implementation shouldn’t be a one-size fits all offer Keeping a company’s DNA front of mind is key to integrating GenAI thoughtfully Read more below! https://lnkd.in/g3SyUEBJ

☀️ As the European tech ecosystem enjoys the summer, what’s better than a bit of reading? Each week this August, we’ll share a selection of reads from our Medium to accompany you on your travels this summer. 🔬Ever wondered what VCs are really looking for during tech assessments? Our latest Medium post dives into the key elements that we look for at Elaia when evaluating tech-intensive startups. Here’s a hint of some of the questions we’ll ask founders when we begin the process of truly understanding how the technology works: 🌠 Uniqueness & Defensibility: How unique and defensible is the tech? 🏎️ Product Readiness: What is the tech maturity? Now and further down the roadmap? 💪 The Tech Team: Is the startup team geared up to take on the challenge of growing the product fast while staying at the cutting edge of tech innovation? Curious to learn more? Read the full article here: https://lnkd.in/e-_Q7Aq6

☀️ As the European tech ecosystem enjoys the summer, what’s better than a bit of reading? Each week this August, we’ll share a selection of reads from our Medium to accompany you on your travels this summer. 💥 What impact could generative AI have on drug discovery? From LLMs for protein structures to scaling the experimentation R&D stage, Part II of our exploration of the intersection of healthcare innovation and GenAI shares our take on the possibilities that could emerge from this collaboration. Want a hint about how we’re going to get there? It’s going to take entrepreneurs and VCs bilingual in both the language of GenAI and biotech to make it happen! To find out more, read below ⬇️ https://lnkd.in/eZWSUiHi

☀️ As the European tech ecosystem enjoys the summer, what’s better than a bit of reading? Each week this August, we’ll share a selection of reads from our Medium to accompany you on your travels this summer. 👩🔬 GenAI + drug discovery = a growing opportunity! Today, drug development can take an average of 10-15 years, from R&D to promotion with a high cost of production. With this extended (and expensive!) timeline in mind, the economic and scientific opportunities offered by generative AI drug development are extensive! Read more about the beginnings of this intertwined approach in part I of our AI x drug discovery investigation on our Medium 👉https://lnkd.in/eWvr7tuW

☀️ As the European tech ecosystem enjoys the summer, what’s better than a bit of reading? Each week this August, we’ll share a selection of reads from our Medium to accompany you on your travels this summer. 🚀Have you ever wondered whether (and when?) you might need a Chief of Staff? Our latest article dives into the nuanced reality of this increasingly key position in tech and deep tech startups. As the tech ecosystem and startups evolve, the Chief of Staff role has often emerged as a crucial element in scaling operations efficiently. However, it's not just about adding a title; it's about understanding the unique blend of adaptability, emotional intelligence, and organizational excellence that a successful CoS can bring to the table at the right moment in a company’s lifecycle. Featuring voices from different Chiefs of Staff in the European tech ecosystem, we look into how this role evolves in early-stage startups and ask the question: could all startups benefit from a Chief of Staff? Read more on our Medium ➡️ https://lnkd.in/eESuDatP

⭐️ Heading to B2B Rocks this September? Find Elaia Partner, Samantha J. onstage on the 25th of September speaking about Future-Proof Funding: What Startups & Scale-Ups Need to Know for 2025 Buy your tickets here! https://lnkd.in/e5yvRUVh

📚 Elaia CEO & Co-founder, Xavier Lazarus, sat down to chat with Zendesk for Startups about our new partnership with Lazard, Lazard Elaia Capital. Read below to learn more about how learn more about how this joint collaboration will unlock growth opportunities in the European tech industry and beyond. Full article here 👉 https://lnkd.in/e4NkarzT

💡 Sustainability Spotlight: Giskard 🌱 As part of our 2023 Sustainability report, we’re highlighting Elaia portfolio companies that are making a difference through commitment to ESG principles. Giskard is the first collaborative & open-source software platform to ensure the quality of AI models. AI models raise many concerns about ethical & security risks. Giskard believes that the only way to mitigate these risks is to test AI models before putting them into production. This is the common practice in mature industries, and Giskard believes it should be the same for AI. Read more about Giskard’s approach to AI models here 👉 https://lnkd.in/dXY-iQpZ Alex Combessie 🐢